Growth rate investigation and tumor lethal dose in Ewing's sarcoma.
D001859:Bone Neoplasms / Q000188:drug therapy / Q000503:physiopathology / Q000532:radiotherapy*; D002648:Child; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000627:therapeutic use; D004307:Dose-Response Relationship, Radiation; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000503:physiopathology / Q000532:radiotherapy; D008297:Male; D008558:Melphalan / Q000627:therapeutic use; D009362:Neoplasm Metastasis; D011379:Prognosis; D011879:Radiotherapy Dosage; D012512:Sarcoma, Ewing / Q000188:drug therapy / Q000401:mortality / Q000503:physiopathology / Q000532:radiotherapy*; D013997:Time Factors; D014747:Vinblastine / Q000627:therapeutic use
D014747:Vinblastine; D003520:Cyclophosphamide; D008558:Melphalan